DocuSign, Inc. (DOCU) Market Cap & Valuation Ratios
DocuSign, Inc. (DOCU) has a market cap of $15.9B, a trailing P/E of 52.0 and a price-to-sales ratio of 4.7, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
DOCUDocuSign, Inc.Follow DOCU — free
—
Price chart with a free account
- Market cap
- 15.9B
- P/E TTM
- 52.0
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Dec, in 39 days
Peers
software - application · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| DOCU | 16 | 52.0 | 4.6 | 29.4 | 7.5% | +9% | 12% | 23% |
| SSNC | 19 | 23.9 | 4.1 | 11.7 | 7.7% | +9% | 24% | 9% |
| DT | 19 | 128.1 | 8.3 | 62.2 | 3.1% | +18% | 12% | 9% |
| U | 18 | — | 8.8 | — | 3.0% | +14% | -30% | -21% |
| FICO | 18 | 23.6 | 9.6 | 18.3 | 5.5% | +24% | 52% | 78% |
| CHKP | 17 | 16.5 | 5.9 | 19.0 | 7.0% | +5% | 30% | 21% |
| TYL | 16 | 51.7 | 6.8 | 32.1 | 4.4% | +8% | 15% | 8% |
| GWRE | 15 | 116.7 | 10.5 | 86.7 | 2.3% | +23% | 10% | 9% |
| MANH | 14 | 68.4 | 12.2 | 48.8 | 2.9% | +6% | 24% | — |
| HUBS | 14 | 96.4 | 3.5 | 42.0 | 4.9% | +21% | 4% | 10% |
| FIG | 13 | — | 8.9 | — | 1.7% | +43% | -124% | -173% |
| Median of these 10 | 60.1 | 8.5 | 37.0 | 3.7% | +16% | 14% | 9% |
P/E 52.0 vs. a peer median of 60.1; EV/Sales 4.6 vs. 8.5. DOCU's own P/E sits at the 69th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesU and FIG have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
DocuSign, Inc. — questions
- What is DocuSign, Inc.'s market cap?
- $15.9B.
- What is DocuSign, Inc.'s P/E ratio?
- 52.0 on trailing twelve-month earnings to 2026-07-31.
- What is DocuSign, Inc.'s price-to-sales ratio?
- 4.7.
Every figure on this page comes from DocuSign, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.